CIK 0001936258 · Large accelerated filer
NewAmsterdam Pharma Co N.V.
Sign in to watch- Ticker
- NAMS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Netherlands
- Entity type
- operating
- Phone
- 35 206 2971
- Business address
- GOOIMEER 2-35, NARRDEN, Netherlands, 1411 DC
- Former names
- NewAmsterdam Pharma Co B.V.
Securities
- NAMS Ordinary Shares Nasdaq
- NAMSW Warrant Nasdaq
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-3 Offering Registration Statement
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at $17.26 ($86,309)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results · Other events
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 3 Insider Initial Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market buy Director bought 8,429 shares at $21.50 ($181,224)
- 4 Open-market sale Chief Scientific Officer sold 190,476 shares at $21.50 ($4,095,234)
- 144 Insider Sale of Securities
- 424B3 Offering Prospectus
Page 13 of 21 · 415 filings